Ironwood Pharma (IRWD) Misses Q1 EPS by 12c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.26), $0.12 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $68.7 million versus the consensus estimate of $81.18 million.

GUIDANCE:

Ironwood Pharma sees FY2019 revenue of $370-390 million, versus the consensus of $388.2 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance